Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial.
暂无分享,去创建一个
[1] J. Katz,et al. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. , 2002, Arthritis and rheumatism.
[2] G. Haugeberg,et al. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. , 2002, Arthritis and rheumatism.
[3] A. Localio,et al. Adjustments for Center in Multicenter Studies: An Overview , 2001, Annals of Internal Medicine.
[4] J. Allison,et al. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. , 2001, The Journal of rheumatology.
[5] J. Gurwitz,et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. , 2001, Archives of internal medicine.
[6] M. Hochberg,et al. Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1996 .
[7] M. Hochberg,et al. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis , 2001 .
[8] C. Cooper,et al. Use of Oral Corticosteroids and Risk of Fractures , 2000 .
[9] G. Haugeberg,et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. , 2000, Arthritis and rheumatism.
[10] N. Lane,et al. Prevention of glucocorticoid-induced osteoporosis: provider practice at an urban county hospital. , 1999, The American journal of medicine.
[11] S. Wallach,et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. , 1999, Arthritis and rheumatism.
[12] N. Freemantle,et al. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? , 1999, JAMA.
[13] C. Cooper,et al. A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update , 1998, Journal of internal medicine.
[14] Jacques P. Brown,et al. Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis , 1998 .
[15] A D Oxman,et al. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[16] C. Goldsmith,et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. , 1994, The Journal of rheumatology.
[17] P. V. van Riel,et al. Low-Dose Prednisone Induces Rapid Reversible Axial Bone Loss in Patients with Rheumatoid Arthritis , 1993, Annals of Internal Medicine.
[18] F. Wolfe,et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. , 1993, The Journal of rheumatology.
[19] L. Melton,et al. Fractures after rheumatoid arthritis. A population-based study. , 1984, Arthritis and rheumatism.